Literature DB >> 8627853

Influence of patient age and co-morbidity on outcome of a collaborative care pathway after radical prostatectomy and cystoprostatectomy.

M O Koch1, J A Smith.   

Abstract

PURPOSE: We determined whether standardized care patterns developed with a collaborative care methodology can be applied successfully across all patient groups with favorable effects on cost and quality.
MATERIALS AND METHODS: We retrospectively analyzed financial and clinical outcomes in 109 radical retropubic prostatectomy and 47 radical cystectomy cases. Patients older than 70 years and/or with an American Society of Anethesiology status of 3 or greater were compared to younger, healthier patients undergoing these procedures.
RESULTS: Standardized care patterns resulted in favorable financial and clinical outcomes in high and low risk patient groups. The only apparent difference was an increased need for rehospitalization after discharge for patients undergoing radical prostatectomy with a high American Society of Anesthesiology status.
CONCLUSIONS: Standardized care patterns developed with a collaborative care methodology provide a high quality, cost-efficient approach to medical care. This methodology is applicable to all patient groups and is highly compatible with current medical practice.

Entities:  

Mesh:

Year:  1996        PMID: 8627853

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Fast-Track Programs for Liver Surgery: A Meta-Analysis.

Authors:  Si-Jia Wu; Xian-Ze Xiong; Jiong Lu; Yao Cheng; Yi-Xin Lin; Rong-Xing Zhou; Nan-Sheng Cheng
Journal:  J Gastrointest Surg       Date:  2015-07-10       Impact factor: 3.452

Review 2.  The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.

Authors:  P T Scardino
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

3.  Prognostic impact of comorbidity in patients with bladder cancer.

Authors:  Ifeanyichukwu I Megwalu; Anna Vlahiotis; Mohamed Radwan; Jay F Piccirillo; Adam S Kibel
Journal:  Eur Urol       Date:  2007-11-05       Impact factor: 20.096

4.  [Radical cystectomy and urinary diversion in elderly patients with increased comorbidity].

Authors:  J E Gschwend; R E Hautmann; B G Volkmer
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

5.  Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series.

Authors:  Derya Tilki; Dirk Zaak; Matthias Trottmann; Alexander Buchner; Yeliz Ekiz; Niklas Gerwens; Boris Schlenker; Alexander Karl; Sebastian Walther; Patrick J Bastian; Christian Gratzke; Stefan Tritschler; Ruth Knüchel-Clarke; Süleyman Ergün; Christian G Stief; Oliver Reich; Michael Seitz
Journal:  World J Urol       Date:  2009-10-22       Impact factor: 4.226

6.  Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure.

Authors:  John P Stein; Donald G Skinner
Journal:  World J Urol       Date:  2006-03-04       Impact factor: 4.226

7.  Implementation of a fast-track clinical pathway decreases postoperative length of stay and hospital charges for liver resection.

Authors:  De-Xin Lin; Xuan Li; Qi-Wen Ye; Fen Lin; Lin-Li Li; Qi-Yu Zhang
Journal:  Cell Biochem Biophys       Date:  2011-11       Impact factor: 2.194

8.  Is the critical pathway effective for the treatment of gastric cancer?

Authors:  Sang-Ho Jeong; Moon-Won Yoo; Hong-Man Yoon; Hyuk-Joon Lee; Hye Sung Ahn; Jae-Jin Cho; Hyung-Ho Kim; Kuhn-Uk Lee; Han-Kwang Yang
Journal:  J Korean Surg Soc       Date:  2011-08-03

Review 9.  Enhanced recovery programmes in hepatobiliary and pancreatic surgery: a systematic review.

Authors:  T C Hall; A R Dennison; D K Bilku; M S Metcalfe; G Garcea
Journal:  Ann R Coll Surg Engl       Date:  2012-07       Impact factor: 1.891

10.  Integrated Care Planning for Cancer Patients: A Scoping Review.

Authors:  Anum Irfan Khan; Erin Arthurs; Sharon Gradin; Marnie MacKinnon; Jonathan Sussman; Vishal Kukreti
Journal:  Int J Integr Care       Date:  2017-11-13       Impact factor: 5.120

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.